Ramon Lopez and Jim McHugh both bring to the firm significant backgrounds in extensive litigation and trial practice, in the many areas of consumer rights, including the following mass tort litigations: Fen-Phen, Breast Implants, Baycol, Rezulin, Sulzer Hips/Knees, PPA, Ephedra, Propulsid, Zyvox, and Zyprexa. Currently the firm is actively involved in litigating the following mass tort cases: Gadolinium/NSF; Ortho Evra Birth Control Patch; Ketek; Guidant and Medtronic defibrillators and pacemakers; drug-eluting coronary stents; Vioxx; Trasylol (aprotinin); Kugel mesh hernia patch; and SSRI anti-depressants causing significant heart and lung birth defects (Paxil, Zoloft, etc.). Ramon Lopez has served or presently serves in leadership positions on plaintiffs' steering or executive committees in various federal multi-district mass tort litigations and state-coordinated mass tort actions around the country. Ramon Lopez was one of four lead plaintiff lawyer negotiators in the Zyprexa litigation, whose efforts resulted in an unprecedented $700 million settlement on behalf of clients from approximately 15 separate law firms, 25% of whose clients were retained by Mr. Lopez's former firm.
The attorneys of Lopez McHugh have set a precedent and track record for defending those who cannot defend themselves and are dedicated and committed to serving their existing and future clients with unprecedented excellence.
Specific Practice Area and Industry Group Details across multiple offices: